Pharmacological models, for example, long-term (4 weeks) subcutaneous administration of Ang II, which disrupts homeostasis by affecting the RAAS, causes increased blood pressure, myocardial hypertrophy, vascular remodeling, and chronic kidney disease, similar to that observed in people suffering from essential hypertension [53,54]. This evidence concerns the gene AGT and hypertensive disorder.